scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.1780380415 |
P698 | PubMed publication ID | 7718010 |
P50 | author | Caroline Gordon | Q58049734 |
P2093 | author name string | A E Johnson | |
P A Bacon | |||
R G Palmer | |||
P433 | issue | 4 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 551-558 | |
P577 | publication date | 1995-04-01 | |
P1433 | published in | Arthritis and Rheumatism | Q23929027 |
P1476 | title | The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth | |
P478 | volume | 38 |
Q34153866 | A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31 |
Q31142463 | A meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those without |
Q35998808 | Applying a new generation of genetic maps to understand human inflammatory disease |
Q35496923 | Association analyses confirm five susceptibility loci for systemic lupus erythematosus in the Han Chinese population |
Q54231271 | Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus. |
Q34064253 | Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus |
Q36528740 | Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium |
Q26778277 | Belimumab in systemic lupus erythematosus |
Q51673006 | Bronchoalveolar lavage fluid cells in mixed connective tissue disease |
Q24793281 | Chronic arthritis in children and adolescents in two Indian health service user populations |
Q38133017 | Clinical aspects of autoimmune rheumatic diseases |
Q38034111 | Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction |
Q36443689 | Contemporary treatment of systemic lupus erythematosus: an update for clinicians. |
Q33813399 | Contraception for adolescents with lupus. |
Q36465492 | Cross-sectional analysis of adverse outcomes in 1,029 pregnancies of Afro-Caribbean women in Trinidad with and without systemic lupus erythematosus |
Q55409997 | Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy. |
Q24243533 | Dehydroepiandrosterone for systemic lupus erythematosus |
Q24245412 | Dehydroepiandrosterone for systemic lupus erythematosus |
Q29417056 | Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production |
Q34128422 | Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitor |
Q38947966 | Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa? |
Q35567251 | Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States |
Q22255575 | Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden |
Q40065685 | Epidemiology of systemic lupus erythematosus: capturing the butterfly. |
Q37335908 | European population substructure is associated with mucocutaneous manifestations and autoantibody production in systemic lupus erythematosus |
Q82298546 | Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement |
Q24562483 | Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans |
Q34319137 | Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus |
Q28550922 | Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide |
Q46681395 | HLA DRB1*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus |
Q24246699 | Herbal medicines for systemic lupus erythematosus |
Q48022368 | High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus |
Q53116103 | Hydroxychloroquine use: the potential impact of new ocular screening guidelines. |
Q21136392 | Identification of unique microRNA signature associated with lupus nephritis |
Q33368979 | Immunopathogenesis of SLE. |
Q34424638 | Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study |
Q62050411 | Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program |
Q34156325 | Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins |
Q40935346 | Interleukin-10 activates heat-shock protein 90beta gene expression |
Q59444498 | Iris heterochromia after vertical squint surgery in a patient with SLE |
Q37468127 | Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: A prospective study of 100 psychiatric inpatients |
Q33670694 | Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome |
Q36683387 | Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus |
Q26740483 | Lupus Nephritis: A Different Disease in European Patients? |
Q46506546 | Malaria and macrophage function in Africans: a possible link with autoimmune disease? |
Q81609248 | New therapies for systemic lupus erythematosus |
Q39367854 | Off-label use of rituximab for systemic lupus erythematosus in Europe |
Q51573777 | Pharmacogenetics of cyclophosphamide and CYP2C19 polymorphism in Thai systemic lupus erythematosus. |
Q34979215 | Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus |
Q34343779 | Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program |
Q38423234 | Prevalence and incidence of systemic lupus erythematosus in South Korea |
Q37334183 | Prevalence of Skin and Skin-Related Diseases in the Rochester Epidemiology Project and a Comparison with Other Published Prevalence Studies |
Q89482953 | Real-world incidence and prevalence of systemic lupus erythematosus in Alberta, Canada |
Q39261499 | Relation of risk of systemic lupus erythematosus to west African admixture in a Caribbean population |
Q24806807 | Risk for rheumatic disease in relation to ethnicity and admixture |
Q35876782 | Selective IgA deficiency in autoimmune diseases |
Q30251721 | Sex differences in the incidence of skin and skin-related diseases in Olmsted County, Minnesota, United States, and a comparison with other rates published worldwide |
Q41033561 | Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease |
Q21195423 | Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis |
Q24543555 | Systemic lupus erythematosus |
Q84420574 | Systemic lupus erythematosus |
Q75828790 | Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity |
Q36577432 | Systemic lupus erythematosus--2005 annus mirabilis? |
Q50848358 | Systemic lupus erythematosus. |
Q51803434 | Systemic lupus erythematosus. |
Q93193261 | Systemic lupus erythematosus: Diagnosis and clinical management |
Q35873057 | Systemic lupus erythematosus: lupus nephritis |
Q36673286 | Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. |
Q85360834 | The Contribution of Meta-Analysis of Genome-Wide Association Studies in Investigating the Genetic Susceptibility to Lupus |
Q34212462 | The epidemiology of autoimmune diseases |
Q35148597 | The epidemiology of systemic lupus erythematosus |
Q36245989 | The genetics of lupus: a functional perspective |
Q38074915 | The humanistic and economic burden of systemic lupus erythematosus : a systematic review |
Q36475637 | The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012. |
Q37754520 | The origin and pathogenic consequences of anti-dsDNA antibodies in systemic lupus erythematosus |
Q62111857 | The polymorphic CYP17 allele is not found with increased frequency in systemic lupus erythematosus |
Q40337416 | The prevalences of some rheumatic diseases in western Turkey: Havsa study |
Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
Q28766942 | Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort |
Q42728756 | Treatment of lupus nephritis |
Q24564906 | Understanding sensitivity and specificity with the right side of the brain |
Q33621131 | Understanding the epidemiology and progression of systemic lupus erythematosus |
Q70994785 | Undiagnosed systemic lupus erythematosus in the community |
Q37106120 | Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative. |
Q45930178 | Valuing Trial Designs from a Pharmaceutical Perspective Using Value-Based Pricing. |
Q53669523 | [Pathogenesis and new therapeutic approaches for systemic lupus erythematosus]. |
Q50691910 | [Systemic lupus erythematosus in Martinique: an epidemiologic study]. |
Search more.